<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Qin F</submitter><funding>Natural Science Foundation of Chongqing (Natural Science Foundation of Chongqing Municipality)</funding><funding>National Natural Science Foundation of China (National Science Foundation of China)</funding><pagination>4828</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12103590</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>16(1)</volume><pubmed_abstract>Ovarian cancer has the highest mortality rate among gynecologic tumors worldwide, with unclear underlying mechanisms of pathogenesis. RNA-binding proteins (RBPs) primarily direct post-transcriptional regulation through modulating RNA metabolism. Recent evidence demonstrates that RBPs are also implicated in transcriptional control. However, the role and mechanism of RBP-mediated transcriptional regulation in tumorigenesis remain largely unexplored. Here, we show that the RBP heterogeneous ribonucleoprotein L (hnRNPL) interacts with chromatin and regulates gene transcription by forming phase-separated condensates in ovarian cancer. hnRNPL phase separation activates PIK3CB transcription and glycolysis, thus promoting ovarian cancer progression. Notably, we observe that the PIK3CB promoter is </pubmed_abstract><journal>Nature communications</journal><pubmed_title>hnRNPL phase separation activates PIK3CB transcription and promotes glycolysis in ovarian cancer.</pubmed_title><pmcid>PMC12103590</pmcid><funding_grant_id>32101164</funding_grant_id><funding_grant_id>82273156</funding_grant_id><funding_grant_id>82072886</funding_grant_id><funding_grant_id>CSTB2023NSCQ-MSX0338</funding_grant_id><funding_grant_id>CSTB2022NSCQ-MSX0897</funding_grant_id><pubmed_authors>Cheng C</pubmed_authors><pubmed_authors>Ren Y</pubmed_authors><pubmed_authors>Zuo X</pubmed_authors><pubmed_authors>Luo F</pubmed_authors><pubmed_authors>Yi P</pubmed_authors><pubmed_authors>Wang H</pubmed_authors><pubmed_authors>Yang D</pubmed_authors><pubmed_authors>Liu T</pubmed_authors><pubmed_authors>Yang C</pubmed_authors><pubmed_authors>Xu J</pubmed_authors><pubmed_authors>Liu X</pubmed_authors><pubmed_authors>Luo Q</pubmed_authors><pubmed_authors>Yang Y</pubmed_authors><pubmed_authors>Wei Q</pubmed_authors><pubmed_authors>Qin F</pubmed_authors><pubmed_authors>Wang W</pubmed_authors><pubmed_authors>Luo X</pubmed_authors><pubmed_authors>Wang Y</pubmed_authors><pubmed_authors>Tang Y</pubmed_authors></additional><is_claimable>false</is_claimable><name>hnRNPL phase separation activates PIK3CB transcription and promotes glycolysis in ovarian cancer.</name><description>Ovarian cancer has the highest mortality rate among gynecologic tumors worldwide, with unclear underlying mechanisms of pathogenesis. RNA-binding proteins (RBPs) primarily direct post-transcriptional regulation through modulating RNA metabolism. Recent evidence demonstrates that RBPs are also implicated in transcriptional control. However, the role and mechanism of RBP-mediated transcriptional regulation in tumorigenesis remain largely unexplored. Here, we show that the RBP heterogeneous ribonucleoprotein L (hnRNPL) interacts with chromatin and regulates gene transcription by forming phase-separated condensates in ovarian cancer. hnRNPL phase separation activates PIK3CB transcription and glycolysis, thus promoting ovarian cancer progression. Notably, we observe that the PIK3CB promoter is </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 May</publication><modification>2026-06-02T02:42:19.736Z</modification><creation>2026-04-13T03:12:25.485Z</creation></dates><accession>S-EPMC12103590</accession><cross_references><pubmed>40413189</pubmed><doi>10.1038/s41467-025-60115-7</doi></cross_references></HashMap>